1. What the invention covers
The present invention provides novel reagents and a cloning procedure based on homologous recombination for the site-directed cloning of a DNA fragment to a vector at designed site(s). The cloning reagents are made of mixture of extracts from at least two different cell types, preferably a mixture made of extracts from wild-type E. coli and S. cerevisiae. Due to the activity of the mixture of cell extracts, recombination occurs between the 3′ and 5′-ends of the target DNA and at the ends of linearized vector, which facilitates in-frame construction of expression vectors.
2. Patent record
Patent owner. Also offers this technology on Innovation Hub.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
REGTECH: THE QUIET TECHNOLOGY GLOBAL BUSINESSES CAN’T DO WITHOUT IT








































